Passa al contenuto
Merck
  • Impact of taurine supplementation on blood pressure in gestational protein-restricted offspring: Effect on the medial solitary tract nucleus cell numbers, angiotensin receptors, and renal sodium handling.

Impact of taurine supplementation on blood pressure in gestational protein-restricted offspring: Effect on the medial solitary tract nucleus cell numbers, angiotensin receptors, and renal sodium handling.

Journal of the renin-angiotensin-aldosterone system : JRAAS (2013-03-08)
José Eduardo Scabora, Marcelo Cardoso de Lima, Agnes Lopes, Ize Penhas de Lima, Flávia Fernandes Mesquita, Daniele Bráz Torres, Patrícia Aline Boer, José Antonio Rocha Gontijo
ABSTRACT

The current study considers changes of the postnatal brainstem cell number and angiotensin receptors by maternal protein restriction (LP) and LP taurine supplementation (LPT), and its impact on arterial hypertension development in adult life. The brain tissue studies were performed by immunoblotting, immunohistochemistry, and isotropic fractionator analysis. The current study shows that elevated blood pressure associated with decreased fractional urinary sodium excretion (FENa) in adult LP offspring was reverted by diet taurine supplementation. Also, that 12-day-old LP pups present a reduction of 21% of brainstem neuron counts, and, immunohistochemistry demonstrates a decreased expression of type 1 angiotensin II receptors (AT1R) in the entire medial solitary tract nuclei (nTS) of 16-week-old LP rats compared to age-matched NP and LPT offspring. Conversely, the immunostained type 2 AngII (AT2R) receptors in 16-week-old LP nTS were unchanged. The present investigation shows a decreased FENa that occurs despite unchanged creatinine clearance. It is plausible to hypothesize an association of decreased postnatal nTS cell number, AT1R/AT2R ratio and FENa with the higher blood pressure levels found in taurine-deficient progeny (LP) compared with age-matched NP and LPT offspring.

MATERIALI
Numero di prodotto
Marchio
Descrizione del prodotto

Sigma-Aldrich
Glicerolo, ACS reagent, ≥99.5%
Sigma-Aldrich
Perossido di idrogeno, contains inhibitor, 30 wt. % in H2O, ACS reagent
Sigma-Aldrich
Glicerolo, Molecular Biology, ≥99.0%
Sigma-Aldrich
Glicerolo, ReagentPlus®, ≥99.0% (GC)
Sigma-Aldrich
Perossido di idrogeno, 30 % (w/w) in H2O, contains stabilizer
Sigma-Aldrich
Triton X-100, laboratory grade
Sigma-Aldrich
DAPI, for nucleic acid staining
Sigma-Aldrich
DL-Dithiothreitol solution, BioUltra, Molecular Biology, ~1 M in H2O
Supelco
DL-Dithiothreitol solution, 1 M in H2O
Sigma-Aldrich
Fenil metansolfonile fluoruro, ≥98.5% (GC)
Sigma-Aldrich
Perossido di idrogeno, 50 wt. % in H2O, stabilized
Sigma-Aldrich
Glicerolo, ≥99.5%
Sigma-Aldrich
Glicerolo, 83.5-89.5% (T)
Sigma-Aldrich
Perossido di idrogeno, 30% (w/w), puriss. p.a., reag. ISO, reag. Ph. Eur.
Sigma-Aldrich
Glicerolo, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for electrophoresis, ≥99% (GC)
Sigma-Aldrich
Glicerolo, BioUltra, Molecular Biology, anhydrous, ≥99.5% (GC)
Supelco
Glicerolo, Pharmaceutical Secondary Standard; Certified Reference Material
Millipore
Perossido di idrogeno, 3%, suitable for microbiology
Supelco
Perossido di idrogeno, ≥30%, for trace analysis
Sigma-Aldrich
Glicerolo, BioXtra, ≥99% (GC)
Sigma-Aldrich
Fenil metansolfonile fluoruro, ≥99.0% (T)
Sigma-Aldrich
Perossido di idrogeno, contains ~200 ppm acetanilide as stabilizer, 3 wt. % in H2O
USP
Glicerina, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Perossido di idrogeno, contains inhibitor, 30 wt. % in H2O, meets USP testing specifications
Sigma-Aldrich
3,3′-diaminobenzidina, tablet, 10 mg substrate per tablet
Sigma-Aldrich
Glicerolo, puriss., anhydrous, 99.0-101.0% (alkalimetric)
Sigma-Aldrich
Glicerolo, FCC, FG
Sigma-Aldrich
Perossido di idrogeno, contains inhibitor, 35 wt. % in H2O
Sigma-Aldrich
Glicerolo, puriss. p.a., ACS reagent, anhydrous, dist., ≥99.5% (GC)
Sigma-Aldrich
Glicerolo, meets USP testing specifications